Augmented reality and virtual reality in the operating theatre status quo und quo vadis

被引:12
|
作者
Sparwasser, Peter Maximilian [1 ]
Schoeb, Dominik [2 ]
Miernik, Arkadiusz [2 ]
Borgmann, Hendrik [1 ]
机构
[1] Univ Med Mainz, Klin & Poliklin Urol & Kinderurol, Langenbeckstr 1, D-55131 Mainz, Germany
[2] Univ Klinikum Freiburg, Klin Urol, Freiburg, Germany
关键词
Augmented Reality; Virtual Reality; Telementoring; Telesurgery; FLEXOR TENDON REPAIR; PARTIAL NEPHRECTOMY; FREEHAND SPECT; GOOGLE GLASS; SURGERY; FEASIBILITY; EDUCATION; CANCER; IMAGE; NODE;
D O I
10.1055/a-0759-0029
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction Virtual reality (VR) is an artificially simulated environment permitting interaction. On the other hand, augmented reality (AR) is an enhanced version of reality created by the use of technology to overlay digital information on an image of something being viewed through a device. Both technologies have partially been implemented in clinical daily routine. Surgical applications of VR and AR are currently evaluated. Yet it is still unclear which possibilities these new and versatile applications offer for physicians. Intention The goal of this article was to assess current and future use of AR und VR, with a special focus on surgery. We also summarised obstacles for AR and VR use as well as potential clinical improvements through these new technologies. Methods Systematic literature research in PubMed with inclusion of reviews referring to AR and VR, especially focused on articles on surgery. Keywords were Augmented Reality, Virtual Reality, Telementoring and Telesurgery. Furthermore we briefly analysed the investment volume and investment strategy in medicine from the ten largest private technology companies of the USA. Results The keyword "Augmented Reality" leads to 1222 articles and 119 reviews, while "Virtual Reality" offered 7766 articles and 878 reviews. In recent years, the amount of published articles has increased. 45 articles were included. Multiple AR- and VR-applications are already integrated in surgical daily routine. The next promising applications will concern the possibility of intraoperative overlap with radiological imaging via AR-tools, as well as telementoring and the use of AR and VR in surgical and anatomical education. The expected - but unproven - advantages include cost savings, reduction in complications, comprehensive knowledge acquisition and improvement in surgical results. In addition, we notice enormous financial investment by technology companies in this sector. Conclusion Due to their tremendous potential, AR and VR technologies will be increasingly integrated into surgery. However, the benefit of these new technologies for relevant endpoints are currently unclear. This should be examined in rigorous clinical trials. Physicians should play a key role in this technological revolution to exploit the potential of AR and VR for their patients.
引用
收藏
页码:500 / 508
页数:9
相关论文
共 50 条
  • [1] XR (Extended Reality: Virtual Reality, Augmented Reality, Mixed Reality) Technology in Spine Medicine: Status Quo and Quo Vadis
    Morimoto, Tadatsugu
    Kobayashi, Takaomi
    Hirata, Hirohito
    Otani, Koji
    Sugimoto, Maki
    Tsukamoto, Masatsugu
    Yoshihara, Tomohito
    Ueno, Masaya
    Mawatari, Masaaki
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (02)
  • [2] Virtual Reality for elderly - status quo and perspectives
    Anghel, Ana Magdalena
    ROMANIAN JOURNAL OF INFORMATION TECHNOLOGY AND AUTOMATIC CONTROL-REVISTA ROMANA DE INFORMATICA SI AUTOMATICA, 2024, 34 (03):
  • [3] The status quo and quo vadis of mast cells
    Maurer, M
    Metz, M
    EXPERIMENTAL DERMATOLOGY, 2005, 14 (12) : 923 - 929
  • [4] Augmented Reality und Virtual Reality
    Matthias Knoll
    Stefan Stieglitz
    HMD Praxis der Wirtschaftsinformatik, 2022, 59 (1) : 1 - 5
  • [5] Vancomycin Resistance: Status Quo and Quo Vadis
    H. P. Endtz
    N. van den Braak
    H. A. Verbrugh
    A. van Belkum
    European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 : 683 - 690
  • [6] Vancomycin resistance: Status quo and quo vadis
    Endtz, HP
    van den Braak, N
    Verbrugh, HA
    van Belkum, A
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) : 683 - 690
  • [7] Genetics of Anxiety Disorders - Status Quo and Quo Vadis
    Domschke, Katharina
    Deckert, Juergen
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (35) : 5691 - 5698
  • [8] PET imaging of gliomas: Status quo and quo vadis?
    Galldiks, Norbert
    Lohmann, Philipp
    Friedrich, Michel
    Werner, Jan-Michael
    Stetter, Isabelle
    Wollring, Michael M.
    Ceccon, Garry
    Stegmayr, Carina
    Krause, Sandra
    Fink, Gereon R.
    Law, Ian
    Langen, Karl-Josef
    Tonn, Joerg-Christian
    NEURO-ONCOLOGY, 2024,
  • [9] DGGG Guidelines Programme: Status Quo - Quo Vadis!
    Beckmann, M. W.
    Linde, I.
    Buetof, C.
    Kreienberg, R.
    Gass, P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2014, 74 (03) : 251 - 259
  • [10] Aspirin in essential thrombocythemia: Status quo and quo vadis
    Griesshammer, M
    Bangerter, M
    Van Vliet, HHDM
    Michiels, JJ
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (04): : 371 - 377